Vanda Pharmaceuticals
Clinical trials sponsored by Vanda Pharmaceuticals, explained in plain language.
-
One patient, one drug: custom gene therapy trial launches for Ultra-Rare disease
Disease control OngoingThis is a highly personalized study for a single patient with a rare genetic nerve disease called CMT2S. The trial is testing the safety of a custom-made drug, VCA-894A, designed to fix a specific genetic error. The drug is injected into the spinal fluid to try to restore a missi…
Phase: PHASE1, PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New topical treatment tested for stubborn toenail fungus
Disease control OngoingThis study is testing a topical solution called VTR-297 (containing Trichostatin A) to see if it's safe and effective for treating toenail fungus. It will involve 50 adults with mild to severe fungal nail infections. Researchers will apply the solution to the affected toenails an…
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New pill tested to stop travel sickness
Symptom relief OngoingThis study is testing a medication called tradipitant to see if it is safe and effective at reducing motion sickness symptoms during travel. It involves 705 adults who have a history of getting motion sick. Participants take the medication before travel situations that normally m…
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Mar 09, 2026 14:25 UTC